Terrence Moorehead
Known title: President and CEOCIK: 0001754431
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nature's Sunshine Q2 Earnings Reviewed Against Peers. A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.
Transaction History
| LFVN | ▲ Buy | Grant | 193,237 | $0 | 10/7/2026 | View on chart |
| LFVN | ▲ Buy | Grant | 308,642 | $0 | 8/6/2026 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 9,302 | $138K | 7/21/2025 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 6,180 | $90K | 3/11/2025 | View on chart |
| NATR | ▲ Buy | Grant | 49,389 | $728K | 3/10/2025 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 9,313 | $145K | 7/21/2024 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 9,560 | $184K | 4/20/2024 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 4,157 | $86K | 3/29/2024 | View on chart |
| NATR | ▲ Buy | Grant | 42,228 | $0 | 3/11/2024 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 8,347 | $115K | 7/21/2023 | View on chart |
| NATR | ▲ Buy | Grant | 65,177 | $0 | 4/20/2023 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 8,850 | $90K | 4/1/2023 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 3,718 | $39K | 3/29/2023 | View on chart |
| NATR | ▲ Buy | Grant | 63,636 | $0 | 7/21/2022 | View on chart |
| NATR | ▲ Buy | Option Exercise | 13,077 | — | 5/3/2022 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 5,147 | $85K | 5/3/2022 | View on chart |
| NATR | ▲ Buy | Option Exercise | 9,805 | — | 4/6/2022 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 3,859 | $65K | 4/6/2022 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 5,021 | $86K | 4/1/2022 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 11,267 | $193K | 3/29/2022 | View on chart |
| NATR | ▲ Buy | Option Exercise | 13,077 | — | 3/18/2022 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 5,147 | $88K | 3/18/2022 | View on chart |
| NATR | ▲ Buy | Option Exercise | 9,804 | — | 3/2/2022 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 2,389 | $42K | 3/2/2022 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 3,177 | $57K | 1/25/2022 | View on chart |
| NATR | ▲ Buy | Option Exercise | 13,077 | — | 1/25/2022 | View on chart |
| NATR | ▲ Buy | Option Exercise | 9,804 | — | 1/14/2022 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 2,790 | $52K | 1/14/2022 | View on chart |
| NATR | ▲ Buy | Option Exercise | 9,804 | — | 10/14/2021 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 3,859 | $57K | 10/14/2021 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 5,147 | $76K | 10/6/2021 | View on chart |
| NATR | ▲ Buy | Option Exercise | 13,077 | — | 10/6/2021 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 15,284 | $241K | 9/14/2021 | View on chart |
| NATR | ▲ Buy | Option Exercise | 9,804 | — | 8/20/2021 | View on chart |
| NATR | ▼ Sell | Tax Withholding | 3,859 | $66K | 8/20/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
LifeVantage Announces Turnaround Plan to Revitalize Brand and Margins
LifeVantage announced a turnaround plan aimed at rebuilding its brand, improving margins, and driving growth. The announcement may influence investor perception as the company seeks to strengthen its financial performance. The move comes as the stock trades near its 25‑touch support level at $6.22.
LifeVantage Announces Turnaround Plan to Revitalize Brand and Margins. LifeVantage announced a turnaround plan aimed at rebuilding its brand, improving margins, and driving growth. The announcement may influence investor perception as the company seeks to strengthen its financial performance. The move comes as the stock trades near its 25‑touch support level at $6.22.